GeneNews Ltd (TSE:GEN – Get Free Report)’s share price traded up 7.1% during trading on Monday . The stock traded as high as C$0.15 and last traded at C$0.15. 473,147 shares were traded during mid-day trading, a decline of 68% from the average session volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Trading Up 7.1 %
The stock’s 50 day moving average is C$0.15. The stock has a market cap of C$25.49 million and a price-to-earnings ratio of -2.21.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Stories
- Five stocks we like better than GeneNews
- What Are Dividend Achievers? An Introduction
- The Charles Schwab Company Can Hit New Highs
- What is a Dividend King?
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.